Education
About Us
Working with TipRanks
Follow Us
XBiotech Inc. (XBIT)
:XBIT
XBIT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.50 - $8.32
Previous CloseN/A
Volume27.99K
Average Volume (3M)138.85K
Market Cap
$90.85M
Enterprise Value-$72.06M
Total Cash (Recent Filing)$155.90M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.22
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jul 15, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)-1.26
Shares Outstanding30,487,732
10 Day Avg. Volume33,803
30 Day Avg. Volume138,847
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)0.49
Price to Sales (P/S)0.00
P/FCF Ratio-2.72
Enterprise Value/Market Cap-0.79
Enterprise Value/Revenue-13.75
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.46
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XBiotech News
PremiumCompany Announcements
XBiotech Appoints New Board Members to Enhance Governance
PremiumCompany Announcements
XBiotech Announces Board Member Retirement
PremiumCompany Announcements
XBiotech Appoints Renowned Scientist to Board of Directors
Options Prices
Currently, No data available
---
Ownership Overview
21.84%
Insiders
5.75% Mutual Funds
0.70% Other Institutional Investors
65.51% Public Companies and
Individual Investors
XBIT FAQ
What was XBiotech Inc.’s price range in the past 12 months?
XBiotech Inc. lowest stock price was $2.50 and its highest was $8.32 in the past 12 months.
What is XBiotech Inc.’s market cap?
XBiotech Inc.’s market cap is $90.85M.
When is XBiotech Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were XBiotech Inc.’s earnings last quarter?
Currently, no data Available
Is XBiotech Inc. overvalued?
According to Wall Street analysts XBiotech Inc.’s price is currently Overvalued.
Does XBiotech Inc. pay dividends?
XBiotech Inc. pays a Notavailable dividend of $2.47 which represents an annual dividend yield of N/A. See more information on XBiotech Inc. dividends here
What is XBiotech Inc.’s EPS estimate?
XBiotech Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XBiotech Inc. have?
XBiotech Inc. has 30,487,732 shares outstanding.
What happened to XBiotech Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of XBiotech Inc.?
Among the largest hedge funds holding XBiotech Inc.’s share is Caxton Associates LP. It holds XBiotech Inc.’s shares valued at 0.
XBiotech Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.40%
12-Months-Change
Fundamentals
Return on Equity
-20.53%
Trailing 12-Months
Asset Growth
-20.19%
Trailing 12-Months
Company Description
XBiotech Inc.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Technical Analysis
Galectin Therapeutics
―
Cellectis SA
―
Anixa Biosciences
―
Renovaro Biosciences
―
Vor Biopharma
―